| Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. | |
| | |
MedLine Citation:
|
PMID: 21490181 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Rhinosinusitis (RS) affects approximately 1 in 7 adults in the United States, and its effect on quality of life, productivity, and finances is substantial. During the past 10 years, several expert panels from authoritative bodies have published evidence-based guidelines for the diagnosis and management of RS and its subtypes, including acute viral RS, acute bacterial RS, chronic RS (CRS) without nasal polyposis, CRS with nasal polyposis, and allergic fungal RS. This review examines and compares the recommendations of the Rhinosinusitis Initiative, the Joint Task Force on Practice Parameters, the Clinical Practice Guideline: Adult Sinusitis, the European Position Paper on Rhinosinusitis and Nasal Polyps 2007, and the British Society for Allergy and Clinical Immunology. Points of consensus and divergent opinions expressed in these guidelines regarding classification, diagnosis, and management of adults with acute RS (ARS) and CRS and their various subtypes are highlighted for the practicing clinician. Key points of agreement regarding therapy in the guidelines for ARS include the efficacy of symptomatic treatment, such as intranasal corticosteroids, and the importance of reducing the unnecessary use of antibiotics in ARS; however, guidelines do not agree precisely regarding when antibiotics should be considered as a reasonable treatment strategy. Although the guidelines diverge markedly on the management of CRS, the diagnostic utility of nasal airway examination is acknowledged by all. Important and relevant data from MEDLINE-indexed articles published since the most recent guidelines were issued are also considered, and needs for future research are discussed. |
| | |
Authors:
|
Eli O Meltzer; Daniel L Hamilos |
Publication Detail:
|
Type: Journal Article; Review Date: 2011-04-13 |
Journal Detail:
|
Title: Mayo Clinic proceedings. Mayo Clinic Volume: 86 ISSN: 1942-5546 ISO Abbreviation: Mayo Clin. Proc. Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-05-02 Completed Date: 2011-07-26 Revised Date: 2011-11-01 |
Medline Journal Info:
|
Nlm Unique ID: 0405543 Medline TA: Mayo Clin Proc Country: United States |
Other Details:
|
Languages: eng Pagination: 427-43 Citation Subset: AIM; IM |
Affiliation:
|
Allergy and Asthma Medical Group and Research Center, 9610 Granite Ridge Dr, Ste B, San Diego, CA 92123, USA. eomeltzer@aol.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Administration, Intranasal Administration, Oral Adrenal Cortex Hormones / administration & dosage Anti-Bacterial Agents / administration & dosage Chronic Disease Clinical Trials as Topic Evidence-Based Medicine Histamine Antagonists / administration & dosage Humans Physician's Practice Patterns / statistics & numerical data Practice Guidelines as Topic* Quality of Life Rhinitis / diagnosis*, drug therapy*, epidemiology Sinusitis / diagnosis*, drug therapy*, epidemiology Sodium Chloride / administration & dosage United States / epidemiology |
| Chemical | |
Reg. No./Substance:
|
0/Adrenal Cortex Hormones; 0/Anti-Bacterial Agents; 0/Histamine Antagonists; 7647-14-5/Sodium Chloride |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Correction of Metatarsus Primus Varus Associated With Hallux Valgus Deformity Using the Arthrex Mini...
Next Document: Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating...